Alembic Pharmaceuticals receives US FDA approval for Doxorubicin Hydrochloride Liposome injection Read more
Nontuberculous mycobacteria market to reach $4.6 billion in 7MM in 2033, forecasts GlobalData Read more
Torrent Pharmaceuticals to acquire controlling stake in JB Pharma from KKR for ₹25,689 crore, followed by merger Read more
Diagnosed prevalent cases of multiple sclerosis to increase by 0.19 per cent AGR in 7MM during 2024-34, forecasts GlobalData Read more
Health Canada approves Biocon Biologics’ YESAFILI, first EYLEA biosimilar, for launch in July 2025 Read more
Punjab Government and Ananya Birla Foundation launch DITSU to strengthen drug abuse response Read more
Kashmik Formulation plans 50 per cent production capacity expansion and targets ₹100 crore revenue in FY26 Read more